Organigram Global Inc.

NASDAQ:OGI

Drug Manufacturers - Specialty & Generic

Healthcare
$0.68 -1.74%

-$0.02 today

Market cap
$95.40M
Beta
1.84
P/E (TTM)
-7.2
EPS (TTM)
-$0.19
52W Low $0.97High $2.24

Volume 0.62M

Average 0.67M

OGI Operating Expenses

Total costs of running the business that are not directly tied to producing goods or services sold.

Organigram Global Inc.NASDAQ: OGI

Operating Expenses · Q2 FY2026 · quarter ended Mar 2026

Operating expenses grows, but more slowly than its trailing trend

Q2 FY2026 operating expenses of CA$26.2M rose 0.8% year over year, behind the +35.4% change in trailing-twelve-month operating expenses. Sequentially, it fell 2.0% from the prior quarter.

Context

  • Operating expenses amounted to 37.7% of revenue in FY2025, down 14.3 pp from a year earlier.
  • Operating expenses increased in 1 of the last 3 fiscal years.
  • FY2025 was the lowest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly growth recovers from +0.8% toward the trailing-twelve-month pace of +35.4%.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterMar 2026
CA$26.2M-2.0% QoQ
Last fiscal yearSep 2025
CA$70.24M-15.6% YoY
LTMMar 2026
CA$111.83M+35.4% YoY
Operating Expenses past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+0.8%——
1 year-15.6%——
3-year CAGR———
5-year CAGR——
10-year CAGR——

Operating Expenses history

CAD · from the income statement

Latest · FY2025
70.24M CAD
Year-over-year change
-15.6%
4-year CAGR
+2.6%

Operating Expenses vs competitors

How OGI compares with its peers on the latest reported figures

  • Peers report in different currencies, so operating expenses is compared through growth and share of revenue rather than absolute size.
  • Its year-over-year change of +35.4% is the 2nd highest of 9, against a peer median of +8.1%.
  • Operating expenses amounts to 40.8% of revenue for OGI, versus a peer median of 70.2%.
OGI Competitors
Operating Expenses for OGI and competitors
Company Period LTM YoY 3-year CAGR% of revenue
ACBAurora Cannabis Inc.LTM Mar 2026CA$175.29M CAD-4.0%-6.8%56.4%
IVAInventiva S.A.FY2025€137.37M EUR+28.7%+22.8%3064.2%
OGIOrganigram Global Inc.LTM Mar 2026CA$111.83M CAD+35.4%—40.8%
OBIOOrchestra BioMed Holdings, Inc.LTM Mar 2026$87.45M USD+22.4%+33.4%267.2%
RNACCartesian Therapeutics, Inc.LTM Mar 2026$80.29M USD-7.3%-1.7%4523.5%
INFUInfuSystem Holdings, Inc.LTM Mar 2026$67.92M USD+4.9%+5.1%47.7%
DERMJourney Medical CorporationLTM Mar 2026$45.41M USD+5.0%-14.0%70.2%
ELMDElectromed, Inc.LTM Mar 2026$42.98M USD+11.1%+12.1%59.9%
LFCRLifecore Biomedical, Inc.LTM Mar 2026$42.21M USD—+4.2%31.2%
HSDTSolana CompanyLTM Mar 2026$27.89M USD+94.3%+18.9%290.8%
Peer median (excluding OGI) —+8.1%+5.1%70.2%

Competitors are the stored peer set for OGI. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

CAD
Metric
FY2021
Aug 2021
FY2022
Aug 2022
FY2023
Sep 2023
FY2024
Sep 2024
FY2025
Sep 2025
Revenue79.16M145.81M149.21M159.84M186.09M
Cost of Revenue107.56M114.24M114.13M112.32M179.26M
Gross Profit(28.4M)31.57M35.07M47.52M6.83M
Gross Margin-35.9%21.7%23.5%29.7%3.7%
Research & Development3.45M5.96M12.19M11.2M10.95M
Selling, General & Admin46.47M59.21M71.68M68.14M86.88M
Operating Expenses63.42M74.72M271.48M83.2M70.24M
Depreciation & Amortization31.03M24.91M23.43M12.08M12.91M
EBITDA(96.71M)10.97M(25.37M)(23.59M)(14.76M)
EBITDA Margin-122.2%7.5%-17.0%-14.8%-7.9%
Operating Income(91.82M)(43.15M)(242.74M)(35.67M)(63.41M)
Operating Margin-116.0%-29.6%-162.7%-22.3%-34.1%
Interest Income003.69M0825.7K
Interest Expense2.96M429K277.85K00
Other Income / Expenses(38.88M)28.78M(184.21M)(9.77M)35.74M
Income Before Tax(130.7M)(14.37M)(233M)(45.44M)(27.66M)
Pre-Tax Margin-165.1%-9.9%-156.2%-28.4%-14.9%
Income Tax Expense0(88K)(3.52M)0(9.89M)
Net Income(130.7M)(14.28M)(229.48M)(45.44M)(17.78M)
Net Margin-165.1%-9.8%-153.8%-28.4%-9.6%
EPS (Basic)(2.04)(0.18)(2.82)(0.48)(0.14)
EPS (Diluted)(2.04)(0.18)(2.82)(0.48)(0.14)
Weighted Avg Shares64.03M80.01M81.29M95.29M127.67M
Weighted Avg Shares (Diluted)64.03M85.3M81.29M95.29M127.67M

Organigram Global Inc.

NASDAQ:OGI

Intrinsic Alpha fair value

Locked

Current Price

$0.68

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.